跳至主要内容
临床试验/JPRN-UMIN000026079
JPRN-UMIN000026079已完成未知

Supportive effect of carnitine on hepatitis C virus eradication therapy - Supportive effect of carnitine on HCV eradication

Third department of Internal Medicine, Nara Medical University0 个研究点目标入组 44 人开始时间: 2017年2月10日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
44

研究概览

简要总结

A significantly smaller decrease in hemoglobin concentration was observed in group B (treated with sofosbuvir, ribavirin, and L-carnitine) compared to group A (treated with sofosbuvir plus ribavirin for 3 months) at every time point. Moreover, the prescribed dose intensity of ribavirin in group B was higher than that of group A, resulting in a higher ratio of sustained virological response (SVR) 24 in group B compared with group A.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with oral intake difficulty 2)Patients with severe digestive disease 3)Pregnant woman, lactating woman, or a woman suspected of pregnancy 4)Patients with severe allergic reaction 5)Patients with drug abuse or psycological disorders 6)Carnitine >=92mmol/

研究者

发起方
Third department of Internal Medicine, Nara Medical University

相似试验

Supportive effect of carnitine on hepatitis C virus... | 临床试验